Conditions: Tinea Pedis
Keywords: Tinea Pedis Ciclopirox Olamine
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 553
Healthy volunteers: no

Brief summary:
The objectives of this study were to demonstrate comparable safety and efficacy of Ciclopirox Olamine Topical Suspension (Test Product) and Ciclopirox Topical Suspension 0.77% (Reference Product) in the treatment of subjects with tinea pedis, and to show the superiority of the active treatments over that of the vehicle.

Detailed description:

Arms:
arm 1: Ciclopirox Olamine Topical Suspension arm 2: Loprox® Topical Suspension 0.77% arm 3: placebo of test product

Interventions: intervention 1: Ciclopirox Olamine Topical Suspension intervention 2: Ciclopirox Topical Suspension 0.77%-Reference Product intervention 3: Ciclopirox Olamine Topical Suspension-Placebo
Intervention descriptions: intervention 1: topical suspension intervention 2: topical suspension intervention 3: topical suspension

Protocol document: